Graham Packham

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Epstein Barr Virus

Machine Learning

Top Venues

Cellular and molecular life sciences : CMLS

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenghao Chen, Helga Simon-Molas, Gaspard Cretenet, Beatriz Valle-Argos, Lindsay D Smith, Francesco Forconi, Bauke V Schomakers, Michel van Weeghel, Dean J Bryant, Jaco A C van Bruggen, Fleur S Peters, Jeffrey C Rathmell, Gerritje J W van der Windt, Arnon P Kater, Graham Packham, Eric Eldering
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood 140 (6) (2022)
Sarah Wilmore, Karly-Rai Rogers-Broadway, Joe Taylor, Elizabeth Lemm, Rachel Fell, Freda K Stevenson, Francesco Forconi, Andrew J Steele, Mark Coldwell, Graham Packham, Alison Yeomans
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells. Cellular and molecular life sciences : CMLS 78 (17-18) (2021)
James Heward, Lola Konali, Annalisa D'Avola, Karina Close, Alison Yeomans, Martin Philpott, James E Dunford, Tahrima Rahim, Ahad F Al Seraihi, Jun Wang, Koorosh Korfi, Shamzah Araf, Sameena Iqbal, Findlay Bewicke-Copley, Emil Kumar, Darko Barisic, Maria Calaminici, Andrew James Clear, John G Gribben, Peter W M Johnson, Richard Neve, Pedro Rodriguez Cutillas, Jessica Okosun, Udo Oppermann, Ari M Melnick, Graham Packham, Jude Fitzgibbon
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas. Blood 138 (5) (2021)
Giorgia Chiodin, Joel D Allen, Dean J Bryant, Philip Rock, Enrica Antonia Martino, Beatriz Valle-Argos, Patrick J Duriez, Yasunori Watanabe, Isla Henderson, James S Blachly, Katy J McCann, Jonathan C Strefford, Graham Packham, Teunis B H Geijtenbeek, Carl G Figdor, George W Wright, Louis M Staudt, W Richard Burack, Thomas A Bowden, Max Crispin, Freda K Stevenson, Francesco Forconi
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior. Blood 138 (17) (2021)
Nicola Normanno, Graham Packham
Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapies. Exploration of targeted anti-tumor therapy 1 (1) (2020)